PMC10401040_01
Overview of the ventricular arrhythmia burden and therapies before and after radiotherapy treatment. The x-axis shows the number of months relative to radiotherapy treatment. In gray, the number of (NS)VT episodes that occurred during the 6-month interval is presented. The green vertical line indicates the timing of the radiotherapy treatments. In the blue box, the lines show the use of the different immunomodulatory drugs over time. In the orange box, the lines show the use of the different anti-arrhythmic drugs over time. The red cross indicates invasive catheter ablations. *Sotalol has been used for less than a week.
fcvm-10-1213165-g001.jpg
PMC10401040_02_fcvm-10-1213165-g001.jpg
F1
Over the course of four years, several endo- and epicardial ablations were performed due to recurrent VT (Figure 1).
PMC10401040_02
Overview of the ventricular arrhythmia burden and therapies before and after radiotherapy treatment. The x-axis shows the number of months relative to radiotherapy treatment. In gray, the number of (NS)VT episodes that occurred during the 6-month interval is presented. The green vertical line indicates the timing of the radiotherapy treatments. In the blue box, the lines show the use of the different immunomodulatory drugs over time. In the orange box, the lines show the use of the different anti-arrhythmic drugs over time. The red cross indicates invasive catheter ablations. *Sotalol has been used for less than a week.
fcvm-10-1213165-g001.jpg
PMC10401040_02_fcvm-10-1213165-g001.jpg
F1
Over the course of four years, several endo- and epicardial ablations were performed due to recurrent VT (Figure 1).